Fortification of Preservation Solution With Nitroprusside Does Not Alter Lung Allograft Survival in Clinical Human Lung Transplantation

REFERENCES

1. 1.↵
   1. Mulligan MS,
   2. Shearon TH,
   3. Weill D,
   4. Pagani FD,
   5. Moore J,
   6. Murray S

   . Heart and lung transplanation in the United States, 1997-2006. Am J Transplant. 2008 Apr;8(4 Pt 2):977-987. doi: 10.1111/j.1600-6143.2008.02175.x.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   1. Diamond JM,
   2. Arcasoy S,
   3. Kennedy CC,
   4. et al.

   Report of the International Society for Heart and Lung Transplantation Working Group on primary lung graft dysfunction, part II: epidemiology, risk factors, and outcomes—a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017 Oct;36(10):1104-1113. doi: 10.1016/j.healun.2017.07.020.

   OpenUrlCrossRef
3. 3.
   1. Christie JD,
   2. Sager JS,
   3. Kimmel SE,
   4. et al.

   Impact of primary graft failure on outcomes following lung transplantation. Chest. 2005 Jan;127(1):161-165. doi: 10.1378/chest.127.1.161.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.
   1. Christie JD,
   2. Bavaria JE,
   3. Palevsky HI,
   4. et al.

   Primary graft failure following lung transplantation. Chest. 1998 Jul;114(1):51-60. doi: 10.1378/chest.114.1.51.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Gray WH,
   2. McFadden PM

   . Commentary: evaluation of primary graft dysfunction after lung transplantation—it is time to teach an old dog new tricks! J Thorac Cardiovasc Surg. 2019 Apr 24. pii: S0022-5223(19)30906-7. doi: 10.1016/j.jtcvs.2019.04.012.

   OpenUrlCrossRef
6. 6.↵
   1. Whitson BA,
   2. Nath DS,
   3. Johnson AC,
   4. et al.

   Risk factors for primary graft dysfunction after lung transplantation. J Thorac Cardiovasc Surg. 2006 Jan;131(1):73-80. doi: 10.1016/j.jtcvs.2005.08.039.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Daud SA,
   2. Yusen RD,
   3. Meyers BF,
   4. et al.

   Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007 Mar 1;175(5):507-513. doi: 10.1164/rccm.200608-1079OC.

   OpenUrlCrossRefPubMedWeb of Science
8. 8.↵
   1. Pinsky DJ,
   2. Naka Y,
   3. Chowdhury NC,
   4. et al.

   The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci U S A. 1994 Dec 6;91(25):12086-12090.

   OpenUrlAbstract/FREE Full Text
9. 9.
   1. Marczin N,
   2. Riedel B,
   3. Gal J,
   4. Polak J,
   5. Yacoub M

   . Exhaled nitric oxide during lung transplantation. Lancet. 1997 Dec 6;350(9092):1681-1682. doi: 10.1016/S0140-6736(05)64281-X.

   OpenUrlCrossRefPubMedWeb of Science
10. 10.↵
    1. Le Cras TD,
    2. McMurtry IF

    . Nitric oxide production in the hypoxic lung. Am J Physiol Lung Cell Mol Physiol. 2001 Apr;280(4):L575-L582. doi: 10.1152/ajplung.2001.280.4.L575.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Meyer KC,
    2. Love RB,
    3. Zimmerman JJ

    . The therapeutic potential of nitric oxide in lung transplantation. Chest. 1998 May;113(5):1360-1371. doi: 10.1378/chest.113.5.1360.

    OpenUrlCrossRefPubMedWeb of Science
12. 12.↵
    1. Botha P,
    2. Jeyakanthan M,
    3. Rao JN,
    4. et al.

    Inhaled nitric oxide for modulation of ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant. 2007 Nov;26(11):1199-1205. doi: 10.1016/j.healun.2007.08.008.

    OpenUrlCrossRefPubMedWeb of Science
13. 13.↵
    1. Pasero D,
    2. Martin EL,
    3. Davi A,
    4. Mascia L,
    5. Rinaldi M,
    6. Ranieri VM

    . The effects of inhaled nitric oxide after lung transplantation. Minerva Anestesiol. 2010 May;76(5):353-361.

    OpenUrlPubMed
14. 14.↵
    1. Yamashita M,
    2. Schmid RA,
    3. Ando K,
    4. Cooper JD,
    5. Patterson GA

    . Nitroprusside ameliorates lung allograft reperfusion injury. Ann Thorac Surg. 1996 Sep;62(3):791-796; discussion 796-797. doi: 10.1016/S0003-4975(96)00439-0.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. King RC,
    2. Binns OA,
    3. Kanithanon RC,
    4. et al.

    Low-dose sodium nitroprusside reduces pulmonary reperfusion injury. Ann Thorac Surg. 1997 May;67(5):1398-1404. doi: 10.1016/s0003-4975(97)00250-6.

    OpenUrlCrossRef
16. 16.↵
    1. Bracken CA,
    2. Gurkowski MA,
    3. Naples JJ

    . Lung transplantation: historical perspective, current concepts, and anesthetic considerations. J Cardiothorac Vasc Anesth. 1997 Apr;11(2):220-241.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Snell GI,
    2. Yusen RD,
    3. Weill D,
    4. et al.

    Report of the ISHLT Working Group on primary lung graft dysfunction, part I: definition and grading—a 2016 consensus group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2017 Oct;36(10):1097-1103. doi: 10.1016/j.healun.2017.07.021.

    OpenUrlCrossRef
18. 18.↵
    Region 3 data for recipient survivorship after lung transplantation based on age. Organ Procurement and Transplantation Network. U.S Department of Health & Human Services. https://optn.transplant.hrsa.gov/data/view-data-reports/regional-data/. Accessed August 13, 2019.